Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.47 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.31 |
| ▸ | TLR2 | O60603 | 4/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | NMT2 | O60551 | 1/20 | 0.30 |
| ▸ | NMT1 | P30419 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30407101 | 0.94 | GLP1R (0.49) | GLP1RCAPN1TDP1LPAR3TLR2 | |
| SCHEMBL30407637 | 0.90 | GLP1R (0.53) | GLP1RLPAR3TLR2TSHRNMT2 | |
| SCHEMBL25551866 | 0.89 | GLP1R (0.52) | GLP1RLPAR3TSHRNMT2NMT1 | |
| SCHEMBL29467628 | 0.84 | GLP1R (0.47) | GLP1RCAPN1TDP1LPAR3TLR2 | |
| SCHEMBL30407445 | 0.83 | GLP1R (0.46) | GLP1RCAPN1TDP1CA1CA2 | |
| SCHEMBL29467696 | 0.82 | GLP1R (0.46) | GLP1RTLR2NMT2NMT1 | |
| SCHEMBL30407201 | 0.81 | GLP1R (0.45) | GLP1RCAPN1TDP1CA1CA2 | |
| SCHEMBL30410601 | 0.81 | GLP1R (0.44) | GLP1RCAPN1TDP1TLR2CA1 | |
| SCHEMBL30407248 | 0.80 | GLP1R (0.44) | GLP1RCAPN1TDP1CA1CA2 | |
| SCHEMBL30407264 | 0.80 | GLP1R (0.43) | GLP1RCAPN1TDP1TLR2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4426741-A1 | BCMA MONOCLONAL ANTIBODY AND THE ANTIBODY-DRUG CONJUGATE | Hangzhou DAC Biotech Co., Ltd. (CN) | 2024-09-11 | — | — | EP | disclosed |
| EP-4426729-A1 | SPECIFIC CONJUGATION FOR AN ANTIBODY-DRUG CONJUGATE | Hangzhou Dac Biotech Co., Ltd. (CN) | 2024-09-11 | — | — | EP | disclosed |
| WO-2023078021-A1 | BCMA MONOCLONAL ANTIBODY AND THE ANTIBODY-DRUG CONJUGATE | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2023-05-11 | — | — | WO | disclosed |
| WO-2023078273-A1 | SPECIFIC CONJUGATION FOR AN ANTIBODY-DRUG CONJUGATE | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2023-05-11 | — | — | WO | disclosed |